Higher Dkk1 doses were necessary for driving a similar pattern of change in the percentage of CD44+CD24-/low, but here the effect was more variable, probably due to lower sensitivity of this assay, so that only the reduction of BC-SC markers under high Dkk1 concentrations showed statistical significance. The gene discussed is CD44; the disease is breast cancer.